In the Wake of the DOJ Settlement, an Orthopedics Industry Split?

When the news came last fall that the five largest orthopedics companies and the US Attorney's office in New Jersey had come to a $311 million settlement following a nearly three-year old investigation into financial and consulting arrangements between those companies and orthopedic surgeons, industry executives across the board, from big and small companies, cheered. But now, just six months after the announcement, the settlement itself has given rise to some controversy and, more importantly, to a potential rift between large and small companies as follow-up efforts to create a more permanent solution have been introduced.